Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone (Q37425629)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2009

Language	Label	Description	Also known as
English	Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone	scientific article published on September 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Frederick L Altice

2

object named as

Frederick L Altice

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

author name string

R Douglas Bruce

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

David E Moody

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Shen-Nan Lin

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Wenfang B Fang

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

John P Sabo

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Jan M Wruck

7

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Peter J Piliero

8

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Carolyn Conner

9

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Laurie Andrews

10

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Gerald H Friedland

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

1 September 2009

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Drug and Alcohol Dependence

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

105

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

234-239

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

Clinical care of the HIV-infected drug user

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

Pharmacokinetic interactions between buprenorphine and antiretroviral medications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

Clinical practice. Office-based treatment of opioid-dependent patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

23 August 2017

Opioid substitution and HIV/AIDS treatment and prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

6 September 2017

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

14 September 2017

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

14 September 2017

Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

14 September 2017

Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

Glucuronidation of buprenorphine and norbuprenorphine by human liver microsomes and UDP-glucuronosyltransferases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

Models for integrating buprenorphine therapy into the primary HIV care setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

Novel metabolites of buprenorphine detected in human liver microsomes and human urine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

Pharmacokinetic characterization of different dose combinations of coadministered tipranavir and ritonavir in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

Buprenorphine versus methadone maintenance: a cost-effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

2 September 2018

Two New Rating Scales for Opiate Withdrawal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2779257

3 December 2018

Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19726139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolism and excretion of buprenorphine in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/19726139

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.DRUGALCDEP.2009.07.007

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37425629&oldid=2143298120"